Skip to main content
BBIO
NASDAQ Life Sciences

BridgeBio Secures Asia Pacific Distribution for ATTR-CM Drug

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$67.2
Mkt Cap
$13.202B
52W Low
$38.575
52W High
$84.94
52W Position info
74% above low
Off High info
21% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BBIO sits 74% above its 52-week low of $38.575.

Summary

BridgeBio Pharma has partnered with DKSH for strategic distribution and commercialization of its transthyretin stabilizer for ATTR-CM in Australia, Singapore, South Korea, and Taiwan. This follows recent positive clinical data and marketing authorization in Brazil for its ATTR-CM drug, Acoramidis. The partnership expands the company's commercial footprint into key Asia Pacific markets, supporting future revenue growth for a significant pipeline asset.

At the time of this announcement, BBIO was trading at $67.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.2B. The 52-week trading range was $38.57 to $84.94. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

BBIO - Latest Insights

BBIO
Oct 29, 2026, 4:52 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $70.69
Real-time Price: $78.01 info
Change: +$7.32 (+10%) info
Market Cap: $15.196B info
BBIO
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.44
Real-time Price: $78.01 info
Change: +$6.57 (+9%) info
Market Cap: $15.196B info
BBIO
Oct 29, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $70.67
Real-time Price: $78.01 info
Change: +$7.34 (+10%) info
Market Cap: $15.196B info
BBIO
Oct 13, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $65.75
Real-time Price: $78.01 info
Change: +$12.26 (+19%) info
Market Cap: $15.196B info
BBIO
Oct 11, 2026, 2:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $65.35
Real-time Price: $78.01 info
Change: +$12.66 (+19%) info
Market Cap: $15.196B info